Avadel Pharmaceuticals PLC (AVDL)
17.40
-0.59
(-3.28%)
USD |
NASDAQ |
Apr 18, 16:00
17.40
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Profit Margin (Quarterly): -148.0% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -148.0% |
September 30, 2023 | -517.2% |
June 30, 2023 | -4.31K% |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | -7.07% |
December 31, 2019 | -24.91% |
September 30, 2019 | -62.30% |
June 30, 2019 | -49.02% |
March 31, 2019 | -79.20% |
December 31, 2018 | -305.3% |
September 30, 2018 | -79.55% |
June 30, 2018 | -11.76% |
March 31, 2018 | -36.75% |
December 31, 2017 | -23.73% |
Date | Value |
---|---|
September 30, 2017 | 54.64% |
June 30, 2017 | 62.46% |
March 31, 2017 | 49.35% |
December 31, 2016 | 10.99% |
September 30, 2016 | -62.31% |
June 30, 2016 | -51.36% |
March 31, 2016 | -16.73% |
December 31, 2015 | |
September 30, 2015 | -59.34% |
June 30, 2015 | -34.69% |
March 31, 2015 | 35.59% |
December 31, 2014 | |
September 30, 2014 | -142.9% |
June 30, 2014 | -488.0% |
March 31, 2014 | -581.9% |
December 31, 2013 | -42.42% |
September 30, 2013 | -114.1% |
June 30, 2013 | -592.9% |
March 31, 2013 | -171.8% |
December 31, 2012 | -80.86% |
September 30, 2012 | -119.0% |
June 30, 2012 | -98.08% |
March 31, 2012 | 0.16% |
December 31, 2011 | -24.18% |
September 30, 2011 | 16.32% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.31K%
Minimum
Jun 2023
-7.07%
Maximum
Mar 2020
-730.8%
Average
-62.30%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
Trinity Biotech PLC | -45.79% |
Medtronic PLC | 16.34% |
Jazz Pharmaceuticals PLC | 9.30% |
Adaptimmune Therapeutics PLC | -20.74K% |
Iterum Therapeutics PLC | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -284.4% |
Return on Assets | -95.14% |
Return on Invested Capital | -141.4% |
Gross Profit Margin (Quarterly) | 96.44% |
Operating Margin (Quarterly) | -128.0% |
Return on Net Operating Assets | -370.3% |